ANGO Stock Summary and Trading Ideas (Angiodynamics | NASDAQ:ANGO)

AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. It generates maximum revenue from Endovascular Therapies. Geographically, the company derives a majority of its revenue from the United States.

Angiodynamics trades on the NASDAQ stock market under the symbol ANGO.

As of April 19, 2024, ANGO stock price climbed to $6.26 with 438,379 million shares trading.

ANGO has a beta of 0.86, meaning it tends to be less sensitive to market movements. ANGO has a correlation of 0.05 to the broad based SPY ETF.

ANGO has a market cap of $250.74 million. This is considered a Small Cap stock.

Last quarter Angiodynamics reported $75 million in Revenue and -$.16 earnings per share. This fell short of revenue expectation by $-548,000 and missed earnings estimates by -$.03.

In the last 3 years, ANGO stock traded as high as $32.00 and as low as $5.26.

The top ETF exchange traded funds that ANGO belongs to (by Net Assets): VTI, IWM, VXF, IWN, KOMP.

ANGO has underperformed the market in the last year with a price return of -30.0% while the SPY ETF gained +21.2%. However, in the short term, ANGO had mixed performance relative to the market. It has outperformed in the last 3 months, returning +7.0% vs +3.0% return in SPY. But in the last 2 weeks, ANGO shares have been beat by the market, returning -11.0% compared to an SPY return of -4.5%.

ANGO support price is $5.87 and resistance is $6.37 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ANGO stock will trade within this expected range on the day.